Asymmetry Capital Management as of June 30, 2016
Portfolio Holdings for Asymmetry Capital Management
Asymmetry Capital Management holds 19 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Centene Corporation (CNC) | 10.7 | $5.9M | 82k | 71.37 | |
| Jazz Pharmaceuticals (JAZZ) | 10.2 | $5.6M | 40k | 141.30 | |
| Eli Lilly & Co. (LLY) | 8.5 | $4.6M | 59k | 78.74 | |
| BIO-RAD LABORATORIES Inc Cl A Com Stk | 8.1 | $4.4M | 31k | 143.03 | |
| Teva Pharmaceutical Industries (TEVA) | 7.7 | $4.2M | 84k | 50.23 | |
| Nevro (NVRO) | 6.8 | $3.7M | 51k | 73.77 | |
| UnitedHealth (UNH) | 6.1 | $3.3M | 24k | 141.20 | |
| Quest Diagnostics Incorporated (DGX) | 5.2 | $2.8M | 35k | 81.42 | |
| Edwards Lifesciences (EW) | 5.2 | $2.8M | 28k | 99.72 | |
| Alere | 4.9 | $2.7M | 64k | 41.69 | |
| Ptc Therapeutics I (PTCT) | 3.9 | $2.2M | 307k | 7.02 | |
| Incyte Corporation (INCY) | 3.7 | $2.0M | 26k | 79.97 | |
| Impax Laboratories | 3.7 | $2.0M | 70k | 28.82 | |
| Ironwood Pharmaceuticals | 2.9 | $1.6M | 121k | 13.07 | |
| Aerie Pharmaceuticals | 2.7 | $1.5M | 84k | 17.60 | |
| Pacira Pharmaceuticals (PCRX) | 2.6 | $1.4M | 42k | 33.74 | |
| Neurocrine Biosciences (NBIX) | 2.5 | $1.4M | 31k | 45.45 | |
| Amicus Therapeutics (FOLD) | 2.3 | $1.3M | 230k | 5.46 | |
| Synergy Pharmaceuticals | 2.1 | $1.1M | 298k | 3.80 |
